November 26, 2021
Japan Tissue Engineering (J-TEC) said on November 25 that it has submitted a notification of the clinical trial plan for its allogeneic cultured epidermis Allo-JaCE03 to the Pharmaceutical and Medical Devices Agency (PMDA). The study aims to validate the efficacy...read more